Резюме
Definição
História e exame físico
Principais fatores diagnósticos
- presence of risk factors
- hypertension
- signs of retinopathy
- oedema
Outros fatores diagnósticos
- poor vision
- numbness of the lower extremities
- pain of the lower extremities
- constitutional symptoms (advanced disease)
- foot changes
- orthostatic hypotension
- skin changes
- muscular atrophy
- pallor (as glomerular filtration rate declines)
- bleeding tendency (advanced disease)
- Kussmaul's respirations (advanced disease)
Fatores de risco
- sustained hyperglycaemia
- hypertension
- family history of hypertension and/or kidney disease
- obesity
- smoking
- physical inactivity
- dyslipidaemia
- high protein, fat, and sodium intake
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- urinalysis
- urinary albumin to creatinine ratio (ACR)
- serum creatinine with GFR estimation
- kidney ultrasound
Investigações a serem consideradas
- cystatin C with GFR estimation
- albumin excretion rate (AER)
- CT abdomen
- magnetic resonance angiography (MRA)
- Doppler ultrasound
- kidney biopsy
Algoritmo de tratamento
type 1 diabetes with nephropathy: not on dialysis
type 2 diabetes with nephropathy: not on dialysis
on peritoneal dialysis or haemodialysis
Colaboradores
Autores
David J. Leehey, MD, FACP

Professor of Medicine
Division of Nephrology
Loyola University Medical Center
Maywood
IL
Declarações
DJL declares that he has no competing interests. DJL is an author of references cited in this topic.
Irfan Moinuddin, MD

Assistant Professor of Medicine
Southern Illinois University School of Medicine
Springfield
IL
Declarações
IM declares that he has no competing interests.
Revisores
Rajiv Agarwal, MD
Professor of Medicine
Department of Medicine
Division of Nephrology
Indiana University School of Medicine
Indianapolis
IN
Declarações
RA declares that he has no competing interests.
Merlin C. Thomas, PhD
Associate Professor
Baker IDI Heart and Diabetes Institute
Melbourne
Australia
Declarações
MCT has received honoraria for speaking and educational sessions conducted by Sanofi-Aventis, Servier, Boehringer-Ingleheim, Abbott, Amgen, and Jansen-Cilag.
Damian Fogarty, BSc, MD, FRCP
Consultant/Senior Lecturer in Renal Medicine
Belfast City Hospital and Queen's University Belfast
Belfast City Hospital
Belfast
Northern Ireland
UK
Declarações
DF has no share options, research support, or employment with pharmaceutical companies. He has received one-time speaking fees to cover his time preparing educational talks in the broad areas of diabetic nephropathy and chronic kidney disease, promoting early recognition and evidence-based or best practice management.
Referências
Principais artigos
American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(suppl 1):S1-321.Texto completo
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022 Nov;102(5s):S1-127.Texto completo Resumo
de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022 Dec 1;45(12):3075-90.Texto completo Resumo
Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022 Nov 1;45(11):2753-86.Texto completo Resumo
Lo C, Toyama T, Wang Y, et al. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database Syst Rev. 2018 Sep 24;(9):CD011798.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Non-diabetic kidney disease
- Multiple myeloma
- Renal tract obstruction
Mais Diagnósticos diferenciaisDiretrizes
- Standards of care in diabetes - 2024
- Newer pharmacologic treatments in adults with type 2 diabetes
Mais DiretrizesFolhetos informativos para os pacientes
Diabetes: What can I do to keep healthy?
Chronic kidney disease: what is it?
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal